Multiparameter Monitors in Massachusetts

Zoe Medical, Inc. is a US-based manufacturer of patient monitoring systems founded in 1996 and headquartered 30 miles north of Boston in Topsfield, Massachusetts. The company has established itself as one of the largest patient monitoring system manufacturers in the United States, with tens of thousands of installed units globally. Zoe designs, manufactures, and supports all products domestically in the USA. Historically, Zoe has operated primarily as an OEM/contract manufacturer for major healthcare organizations. The company now distributes its own-label monitoring products at factory-direct pricing, targeting physician offices, oral and outpatient surgery centers, emergency medical services (EMS), and central monitoring stations. Product portfolio includes the Nightingale series (PPM3 for oral/outpatient surgery, PHM compact spot-check monitor with thumb ECG for physician offices, and MPC nurse central station for alarm surveillance and trending) and the 740SELECT multiparameter monitor for EMS and vital signs applications. All monitors support standard vital sign parameters including ECG, blood pressure, pulse oximetry, temperature, and capnography. The company emphasizes substantial R&D investment, proprietary product architecture, and manufacturing capability. Products are designed for clinical environments ranging from point-of-care physician offices to operating rooms, EMS transport, and hospital central monitoring. Zoe maintains direct customer support and offers sales quotes and customized solutions. All manufacturing and technical support are US-based.

VUNO Med, Inc. develops AI-driven diagnostic and patient monitoring software solutions for healthcare providers. The company manufactures two principal FDA-cleared products: VUNO Med®-DeepCARS®, an early warning system for cardiac arrest risk assessment in general ward inpatients using vital signs monitoring (heart rate, blood pressure, respiratory rate, oxygen saturation, plus age and timing); and VUNO Med®-Chest X-ray™ Triage, an AI-based diagnostic support system for detecting suspected chest abnormalities and major pulmonary diseases from chest radiography. Both products integrate deep learning algorithms with clinical workflows to assist healthcare professionals in reducing response times, lowering clinical costs, and improving patient outcomes. The DeepCARS system has been prospectively validated in multicentre studies published in peer-reviewed journals including Critical Care Medicine and Resuscitation, demonstrating predictive value for in-hospital cardiac arrest and unplanned ICU transfer. The Chest X-ray Triage system has undergone external validation for detection of nodular and reticular opacities in interstitial lung disease and other pulmonary conditions. VUNO distributes its solutions primarily to hospitals and health systems in the United States and maintains clinical advisory relationships with leading academic medical centers. The company emphasizes regulatory compliance and clinical evidence to support adoption in acute care settings.

Nova Biomedical is a privately held, globally-leading in vitro diagnostic (IVD) company founded in 1976 and headquartered in Waltham, Massachusetts. The largest privately owned diagnostic company in the United States, Nova Biomedical employs over 1,500 people across manufacturing facilities in Massachusetts and Taipei, Taiwan, serving 110+ countries through its global distributor network. The company specializes in advanced blood testing and analytical instrumentation, with a comprehensive portfolio including critical care blood gas analyzers (StatProfile® Prime series), point-of-care glucose meters (StatStrip®, NovaMax®), cell culture analyzers (BioProfile® Flex), clinical and bioprocessing osmometers, liquid volume verification systems, and automated CSF cell counters. Nova Biomedical serves hospitals, emergency departments, blood banks, biotech/pharmaceutical manufacturers, clinical research laboratories, and veterinary diagnostics markets. The company operates through multiple trusted brand portfolios including Advanced Instruments, BioProfile, StatProfile, StatStrip, Artel, Solentim, and GloCyte, delivering solutions for bioprocessing, clinical diagnostics, and veterinary applications with emphasis on improving patient outcomes and operational efficiency.